Clinical Trial Update: Effect of Pulsatile IV Insulin on Circulating Risk Markers of Vascular and Metabolic Complications in Pts With Diabetes [Phase 2, Phase 3]

View source ↗

Summary

The Phase 2/3 clinical trial evaluating pulsatile intravenous insulin in people with diabetes has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Pulsatile intravenous insulin (insulin)

Snippet

Sponsor: Florida Atlantic University | Conditions: Diabetes Mellitus | Phase 2, Phase 3 | Status: TERMINATED